Inclusion Criteria:

• Gender minority is defined using NIH’s definition as anyone whose gender identity differs from that assigned at birth, who may reject binary male-female self-identification, and/or who may identify as transgender, nonbinary, two spirit, or additional gender diverse identity labels.
• Sexual minority cisgender man is defined as a person assigned male at birth who identifies as a man and who also self-identifies as gay or bisexual. This definition also includes men whose attractions and/or behavior are significantly towards other men.
• Sexual minority cisgender woman is defined as a person assigned female at birth who identifies as a woman and who also self-identifies as lesbian, gay, or bisexual. This definition also includes women whose attractions and/or behavior are significantly towards other women.
• Heterosexual cisgender man or woman is defined as a person assigned male at birth who identifies as a man (cisgender man) or a person assigned female at birth who identifies as a woman (cisgender woman) and who self-identifies as straight or heterosexual and whose attractions and behaviors are exclusively towards women for men and men for women.
• Age is restricted to persons 18 years and older.
• Currently residing in the US.
• Diagnosed with and treated for cancer.
• English speaking.

Exclusion Criteria:

• Because one of the main hypotheses of the entire project is to investigate the effects of treatment on willingness to participate in cancer research, patients who have been diagnosed but who have not yet received a medical treatment, including those under “active surveillance”, are excluded.
• Cognitive Impairment
• Non-English speaking/reading

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 08/22/2024. Questions regarding updates should be directed to the study team contact.